RCKT FY 2016 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$538M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$169,000

Operating Income

-$42M

Net Income

-$43M

EPS (Diluted)

$-6.41

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$130M

Total Liabilities

$56M

Stockholders' Equity

$73M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$169,000	-$45,000	-275.6%
Operating Income	-$42M	-$20M	-105.3%
Net Income	-$43M	-$68M	+37.0%